The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 137K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Algeciras, A.
Right arrow Articles by Paya, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Algeciras, A.
Right arrow Articles by Paya, C. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/3/711/ $5.00
The Journal of Experimental Medicine, Volume 187, Number 5, March 2, 1998 711-720


Articles

CD4 Regulates Susceptibility to Fas ligand– and Tumor Necrosis Factor–mediated Apoptosis

Alicia Algeciras*, David H. Dockrell{ddagger}, David H. Lynch§, and Carlos V. Paya*,{ddagger}

From the * Department of Immunology and the {ddagger} Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota 55905; and the § Department of Immunobiology, Immunex Corporation, Seattle, Washington 98101

The current knowledge of CD4 function is limited to its role as a necessary coreceptor in TCR-initiated signaling. We have investigated whether CD4 regulates additional T cell functions. Using human primary resting CD4+ T cells, we demonstrate that CD4 activation is sufficient to induce lymphocyte death. Immediately after CD4 cross-linking, CD4+ T cells are rendered susceptible to apoptosis mediated by TNF or FasL. This, together with the concomitant induction of FasL within the same population, results in significant CD4+ T cell death in vitro. The CD4-dependent induction of susceptibility to apoptosis that is mediated by TNF or FasL is protein synthesis independent but phosphorylation dependent. After CD4 activation, PKC regulates susceptibility to apoptosis mediated by FasL but not the induction of susceptibility to TNF-dependent apoptosis. Moreover, significant differences between CD3 and CD4 activation were observed with regards to the kinetics of induction of CD4+ T cell susceptibility to FasL- and TNF-mediated apoptosis. Altogether, these results provide a model with which to study the molecular mechanisms regulating lymphocyte survival after CD4 activation, and highlight the potential role of CD4 in controlling lymphocyte apoptosis under physiological conditions or in disease states such as HIV infection.


We thank Dr. Hideo Yagita for the NOK1-PE antibody, Dr. Robert Abraham for the anti-CD3 antibody, and Teresa Hoff for outstanding secretarial assistance. We also acknowledge Dr. Paul Leibson and the rest of Carlos Paya's laboratory for helpful discussions.

Address correspondence to Carlos V. Paya, Mayo Clinic, 200 First St. SW, Guggenheim 501, Rochester, MN 55905. Phone: 507-284-3747; Fax: 507-284-3757; E-mail: paya{at}mayo.edu

1 Abbreviations used in this paper: FasL, Fas ligand; GF, PKC inhibitor GF109203X; gp, glycoprotein; PKC, protein kinase C; XL, cross-linking.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS